Medical Diagnostic Reagent Manufacturing

The contract pertains to the manufacture and quality control of liquid general chemistry and lipid control combo kits designed for use with PICCOLO EXPRESS analyzers, encompassing the full lifecycle from formulation to stability testing and quality assurance. The work involves precise reagent development to ensure consistent performance, accuracy, and reliability in clinical diagnostics, with all processes adhering to strict regulatory and technical specifications. The manufacturer is expected to implement rigorous quality systems to validate product consistency and shelf life under defined environmental conditions, ensuring compatibility and optimal function with the target analyzer platform. This is a subcontract solicitation issued by the Department of Defense under the Medical Supply Chain MD Surg FSF, with the NAICS code 325412 indicating classification under Pharmaceutical and Medicine Manufacturing. The solicitation was posted on July 15, 2026, with a mandatory response deadline of July 21, 2026. The place of performance and specific location details are not provided, suggesting flexibility in manufacturing site selection, but all production must meet federal procurement standards for medical diagnostic products. The contract is part of a broader effort to secure reliable supply chains for diagnostic reagents used in military and veteran healthcare settings.